What is the clinical evidence from this study?

Study design: Observational. Population: Diverse populations (knowledge workers, type 1 diabetes, student interns, traumatic brain injury, college students) (n=1430). Intervention: Resting heart rate variability (HRV) measured by consumer wearables. Primary outcome: Association between resting HRV and Hba1c (r = -0.21, p=0.014).

What does this research mean for the field?

Resting heart rate variability measured by consumer wearables exhibits small-to-moderate associations with diverse clinical and trait-like health measures, including HbA1c, depressive symptoms, and sleep difficulty, supporting its potential as a general health biomarker. Novelty: ClaimNovelty.CONFIRMATORY. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

To assess the validity of resting heart rate variability measured by consumer wearables as a general health indicator across physical, mental, behavioral, functional, and physiological domains.

November 22, 2025SensorsOpen Access

Resting Heart Rate Variability Measured by Consumer Wearables and Its Associations with Diverse Health Domains in Five Longitudinal Studies

Q: What are the key findings of this study?

Wearable-measured resting HRV had small-to-moderate associations with clinically oriented health measures such as Hba1c (r = -0.21, p=0.014) and depressive symptoms (r = -0.22, p=0.024).

View Full Paper

Ask AI

Bookmark

Key result

Wearable resting HRV shows modest inverse links to HbA1c and depressive symptoms.

r = -0.21
P=0.014
n=1,430

Why the study?

Consumer wearables offer wide accessibility to capture heart rate variability (HRV), but the validity of wearable-measured HRV as a general health indicator required investigation.

Does resting HRV measured by consumer wearables correlate with diverse health domains in various populations?

Key Points

To assess the validity of resting heart rate variability measured by consumer wearables as a general health indicator across physical, mental, behavioral, functional, and physiological domains.
Analyzed data across five longitudinal studies involving clinical cohorts (type 1 diabetes, traumatic brain injury) and non-clinical groups (knowledge workers, interns, college students).
Assessed resting heart rate variability (RMSSD) during stationary states (upon waking or during sleep) using two smartwatches, two chest straps, and one smartring.
Evaluated within-person and between-person multilevel correlations between RMSSD and ecological momentary assessments, baseline surveys, and clinical biomarkers.
Wearable-measured resting RMSSD correlated with baseline clinical markers, including lower Hba1c (r = −0.21, p = 0.014), lower triglycerides (r = −0.17, p = 0.006), and lower depression symptoms (r = −0.22, p = 0.024).
Resting RMSSD showed significant between-person associations with sleep difficulty (r = −0.11, p = 0.003), fluid intelligence (r = 0.10, p = 0.021), diabetic neuropathy (r = −0.28, p = 0.007), and retinopathy (r = −0.39, p < 0.001).
Within-person correlations between daily resting RMSSD and day-to-day fluctuations in general stress and mood were generally weak and non-significant, while RMSSD intraclass correlation coefficients ranged from 0.55 to 0.89.

Study Design

Type

Observational (n=1,430)

Multicenter

Yes

Structured PICO

Does resting HRV measured by consumer wearables correlate with diverse health domains in various populations?

Population

1,430 participants across five longitudinal studies (including healthy adults, students, and patients with type 1 diabetes or traumatic brain injury) who recorded resting HRV using consumer wearables.

Exposure

Resting heart rate variability (HRV) measured by consumer wearables (smartwatches, chest straps, smartring) upon waking or while sleeping

Outcome

Associations with diverse health domains (mental, physical, behavioral, functional, and physiological)surrogate

Main Result

Effect estimate: r = -0.21

p-value: p=0.014

Resting HRV measured by consumer wearables shows potential as a digital biomarker for general health, particularly correlating with clinically oriented trait-like measures.

Limitations

Lack of control over sampled individuals and collected variables due to secondary data analysis
Potential measurement error from wearables
Validity of the HRV measures against gold-standard ECG was not formally examined
Small sample sizes in some of the included studies
No adjustment for multiple comparisons
Secondary data analysis limitations (no control over design/variables)
Measurement error from wearables
No formal comparison to gold-standard ECG
Small sample sizes in some studies

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

May support wearable HRV as digital biomarker; leaves open its incremental value for clinical decision-making.

Cite This Study

Hernandez et al. (2025) conducted an observational in Diverse populations (knowledge workers, type 1 diabetes, student interns, traumatic brain injury, college students) (n=1,430). Resting heart rate variability (HRV) measured by consumer wearables was evaluated on Association between resting HRV and Hba1c (r = -0.21, p=0.014). Wearable-measured resting HRV had small-to-moderate associations with clinically oriented health measures such as Hba1c (r = -0.21, p=0.014) and depressive symptoms (r = -0.22, p=0.024).

synapsesocial.com/papers/6a1d81b173c56dd1bd2fc607 https://doi.org/10.3390/s25237147

View Full Paper

Ask AI

Bookmark

Resting Heart Rate Variability Measured by Consumer Wearables and Its Associations with Diverse Health Domains in Five Longitudinal Studies

Key Points

Study Design

Structured PICO

Main Result

Limitations

Discussion

Implication

Cite This Study

Resting Heart Rate Variability Measured by Consumer Wearables and Its Associations with Diverse Health Domains in Five Longitudinal Studies

Key Points

Study Design

Structured PICO

Main Result

Limitations

Discussion

Implication

Cite This Study

Also Consider

Also Consider